These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14625345)

  • 21. Oxidation of caffeine by CYP1A2: isotope effects and metabolic switching.
    Regal KA; Kunze KL; Peter RM; Nelson SD
    Drug Metab Dispos; 2005 Dec; 33(12):1837-44. PubMed ID: 16135658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoterpene biosynthesis: isotope effects associated with bicyclic olefin formation catalyzed by pinene synthases from sage (Salvia officinalis).
    Wagschal KC; Pyun HJ; Coates RM; Croteau R
    Arch Biochem Biophys; 1994 Feb; 308(2):477-87. PubMed ID: 8109978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-temperature rapid-scan detection of reactive intermediates in epoxidation reactions catalyzed by a new enzyme mimic of cytochrome p450.
    Hessenauer-Ilicheva N; Franke A; Meyer D; Woggon WD; van Eldik R
    J Am Chem Soc; 2007 Oct; 129(41):12473-9. PubMed ID: 17880072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: time dependency and reversibility profiles in isolated perfused rat livers.
    Vuppugalla R; Mehvar R
    Drug Metab Dispos; 2004 Dec; 32(12):1446-54. PubMed ID: 15383494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs.
    Obach RS
    Drug Metab Dispos; 2001 Dec; 29(12):1599-607. PubMed ID: 11717179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of the reaction energetics for cytochrome P450-mediated reactions.
    Higgins L; Korzekwa KR; Rao S; Shou M; Jones JP
    Arch Biochem Biophys; 2001 Jan; 385(1):220-30. PubMed ID: 11361021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prochiral selectivity and intramolecular isotope effects in the cytochrome P-450 catalyzed omega-hydroxylation of cumene.
    Sugiyama K; Trager WF
    Biochemistry; 1986 Nov; 25(23):7336-43. PubMed ID: 3801417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
    Hollenberg PF; Kent UM; Bumpus NN
    Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The complexities inherent in attempts to decrease drug clearance by blocking sites of CYP-mediated metabolism.
    Fisher MB; Henne KR; Boer J
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):101-9. PubMed ID: 16445122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic Deuterium Isotope Effects in Cytochrome P450 Reactions.
    Guengerich FP
    Methods Enzymol; 2017; 596():217-238. PubMed ID: 28911772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic isotope effects implicate a single oxidant for cytochrome P450-mediated O-dealkylation, N-oxygenation, and aromatic hydroxylation of 6-methoxyquinoline.
    Dowers TS; Jones JP
    Drug Metab Dispos; 2006 Aug; 34(8):1288-90. PubMed ID: 16714370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxidases: a role in the metabolism and side effects of drugs.
    Tafazoli S; O'Brien PJ
    Drug Discov Today; 2005 May; 10(9):617-25. PubMed ID: 15894226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomimetic alcohol oxidations by an iron(III) porphyrin complex: relevance to cytochrome P-450 catalytic oxidation and involvement of the two-state radical rebound mechanism.
    Han JH; Yoo SK; Seo JS; Hong SJ; Kim SK; Kim C
    Dalton Trans; 2005 Jan; (2):402-6. PubMed ID: 15616733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the enzymic mechanism of Candida tenuis xylose reductase (AKR 2B5): X-ray structure and catalytic reaction profile for the H113A mutant.
    Kratzer R; Kavanagh KL; Wilson DK; Nidetzky B
    Biochemistry; 2004 May; 43(17):4944-54. PubMed ID: 15109252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y; Horie T
    Crit Rev Toxicol; 2007 Jun; 37(5):389-412. PubMed ID: 17612953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stochastic simulations of the cytochrome P450 catalytic cycle.
    Wang Y; Li Y; Wang B
    J Phys Chem B; 2007 Apr; 111(16):4251-60. PubMed ID: 17402779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of ionizable residues in the catalytic mechanism of tryptophan synthase from Salmonella typhimurium.
    Raboni S; Mozzarelli A; Cook PF
    Biochemistry; 2007 Nov; 46(45):13223-34. PubMed ID: 17927213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.